Best in Biotech 2 Sep 2021
The Top 15 Biotech Companies to Find in Amsterdam
Known for its nightlife and the beauty of its canals, Amsterdam is also the home of many innovative companies within…
Kiadis Pharma
- Latest Posts
News and Trends 23 Feb 2021
European Cancer Deals Increasingly Focus on Natural Killer Cells
Natural killer cells are becoming a hot topic in the booming cancer cell therapy scene, with the field’s latest big…
News and Trends 17 Dec 2020
Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American Society of Hematology (ASH) displayed…
News and Trends 3 Nov 2020
Kiadis’ Natural Killer Cell Therapies Earn €308M Acquisition by Sanofi
The French big pharma Sanofi has offered €308M to acquire the Dutch firm Kiadis Pharma and get hold of cancer…
ADVERTISEMENT
News and Trends 13 Jul 2020
Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal
The Dutch biotech Kiadis Pharma has licensed an off-the-shelf cell therapy program to the pharma giant Sanofi for up to…
News and Trends 13 Nov 2019
Mass Layoffs as Dutch Biotech Cancels Phase III Cell Therapy Trial
The Dutch company Kiadis Pharma has discontinued the development of a cell therapy in blood cancer, laid off half of…
News and Trends 3 Jun 2019
Dutch Company Raises €28M to Push Cancer Cell Therapy to European Market
The Dutch Kiadis Pharma has raised €27.6M in a private placement to fund the clinical development of immune cell therapies…
In Depth 23 Jan 2018
Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?
Although biotech may seem like an industry that has only just gotten started, it was already up and running before…
News and Trends 4 Dec 2017
Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching
Kiadis Pharma starts Phase III trials with ATIR101, a therapy that could make half-matched donors suitable for bone marrow transplant…
News and Trends 20 Sep 2017
Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment
The FDA has backed Kiadis Pharma's lead blood cancer product by granting it the Regenerative Medicine Advanced Therapy designation. Kiadis Pharma,…
ADVERTISEMENT
Interview 22 May 2017
Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer
Arthur Lahr, CEO of Kiadis Pharma, explains the promising cell therapy the company is developing and discusses how the dutch…
News and Trends 26 Apr 2017
BRIEF: Dutch Biotech Goes for MAA in the EU with new Immunotherapy
Kiadis Pharma has applied for marketing authorization from the EMA for its T cell immune therapy, which could halt graft-versus-host…
News and Trends 15 Dec 2016
Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials
Kiadis Pharma has received approval to test in the UK an immune therapy to address the big challenges of bone…
News and Trends 6 Dec 2016
How is European Immuno-Oncology fighting Blood Cancer?
From leukemia to multiple myeloma, biotech is working hard to cure blood cancer. This year's edition of the American Society…
News and Trends 28 May 2016
It’s Blood Cancer Day, how is Biotech fixing it?
Today is the World Blood Cancer Day, an event to show solidarity to patients and raise awareness for the need…
News and Trends 15 Jan 2016
Biotech of the week: Kiadis Pharma, Immuno-therapy made in Amsterdam
This week we say 'auf Wiedersehen' to Germany and head West to the Netherlands and it's capital city, Amsterdam. This…
ADVERTISEMENT
News and Trends 10 Dec 2015
Infographic: The Anatomy of European Biotech
Which part of our body do European biotechs prefer to target? And how diversified are the biotech companies in Europe…
News and Trends 6 Jul 2015
Kiadis launches its Cell-based Immunotherapies on European stock markets
Kiadis Pharma has launched an IPO on Euronext Amsterdam and Euronext Brussels with the aim of raising €32.7M. The company…